D. E. Shaw & Co., Inc. - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 74 filers reported holding SERES THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$148,000
-78.3%
43,148
-54.9%
0.00%
-100.0%
Q1 2022$681,000
+180.2%
95,638
+228.3%
0.00%
Q4 2021$243,000
+115.0%
29,132
+80.0%
0.00%
Q3 2021$113,000
-91.0%
16,188
-69.2%
0.00%
-100.0%
Q2 2021$1,252,000
+16.7%
52,480
+0.7%
0.00%0.0%
Q1 2021$1,073,000
-88.9%
52,118
-86.8%
0.00%
-88.9%
Q4 2020$9,677,000
-31.4%
395,001
-20.7%
0.01%
-35.7%
Q3 2020$14,097,000
+263.3%
497,935
-38.9%
0.01%
+180.0%
Q2 2020$3,880,000
+122.2%
815,162
+66.6%
0.01%
+66.7%
Q1 2020$1,746,000
+40.0%
489,179
+35.4%
0.00%
+200.0%
Q4 2019$1,247,000
+20.6%
361,414
+40.1%
0.00%0.0%
Q3 2019$1,034,000
+1.7%
257,978
-18.3%
0.00%0.0%
Q2 2019$1,017,000
-48.1%
315,823
+10.7%
0.00%
-66.7%
Q1 2019$1,960,000
+40.8%
285,305
-7.3%
0.00%
+50.0%
Q4 2018$1,392,000
-36.9%
307,930
+5.9%
0.00%
-33.3%
Q3 2018$2,206,000
-11.2%
290,736
+0.6%
0.00%0.0%
Q2 2018$2,485,000
+12.7%
288,962
-3.8%
0.00%0.0%
Q1 2018$2,204,000
-42.9%
300,297
-21.1%
0.00%
-40.0%
Q4 2017$3,858,000
-56.2%
380,433
-30.7%
0.01%
-64.3%
Q3 2017$8,802,000
+47.7%
548,748
+4.1%
0.01%
+40.0%
Q2 2017$5,958,000
-8.6%
527,261
-8.8%
0.01%
-9.1%
Q1 2017$6,517,000
+22.3%
578,301
+7.4%
0.01%
+22.2%
Q4 2016$5,330,000
-17.4%
538,382
+2.5%
0.01%
-18.2%
Q3 2016$6,456,000
+2239.1%
525,302
+5429.5%
0.01%
+1000.0%
Q2 2016$276,0009,5000.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 21,571,764$610,696,00016.87%
RA Capital Management 4,750,000$134,473,0002.46%
ARK Investment Management 12,293,033$348,016,0002.06%
Opaleye Management Inc. 335,312$9,493,0001.86%
Sio Capital Management, LLC 316,800$8,969,0001.78%
Ikarian Capital, LLC 762,400$21,585,0001.56%
Nikko Asset Management Americas, Inc. 5,531,670$152,176,0001.35%
EAM Global Investors LLC 121,629$3,443,0001.26%
EAM Investors, LLC 133,591$3,782,0000.90%
GILDER GAGNON HOWE & CO LLC 3,185,420$90,179,0000.56%
View complete list of SERES THERAPEUTICS INC shareholders